secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-06-18T13:19:55+00:00
Accession:  0001683168-26-004956
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Valion Bio issues $250K in Series B Preferred and warrants to 3i, LP
--------------------------------------------------------------------

- Issued 250 Series B Preferred shares at $1,000 each and a warrant for 156,026 common shares at $0.61628 per share.
- Aggregate purchase price of $250,000 received from 3i, LP.
- Securities issued under Section 4(a)(2) and Rule 506(b) exemption from registration.
- Purchase agreement originally with an investor, assigned to 3i, LP on December 9, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826004956/0001683168-26-004956-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826004956/valion_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-004956

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer